A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo ® Temporary Pacing Lead was featured in a ...

A fully implantable, bioabsorbable pacemaker has been developed that's capable of sustaining heart rhythms in animal and human donor hearts before disappearing over 5 to 7 weeks. Temporary pacing ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Annual Transcatheter Valve ...

Temporary pacing leads are getting more stage time as doctors try to head off a common heart block complication from TAVR. BioTrace Medical Inc.'s new Tempo lead aims to make temporary pacing more ...

The cardiac pacemaker harmlessly dissolves over the course of 35 days. (Courtesy: Northwestern University) Temporary cardiac pacemakers provide essential pacing for patients with short-term heart ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the ...